Principal Financial Group Inc. Boosts Holdings in Sabra Healthcare REIT, Inc. $SBRA

Principal Financial Group Inc. raised its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.4% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 25,052,121 shares of the real estate investment trust’s stock after buying an additional 98,770 shares during the period. Principal Financial Group Inc. owned approximately 0.10% of Sabra Healthcare REIT worth $481,755,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of SBRA. PNC Financial Services Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 2.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after acquiring an additional 528 shares during the last quarter. Larson Financial Group LLC lifted its stake in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the last quarter. Anchor Investment Management LLC lifted its stake in Sabra Healthcare REIT by 15.5% during the third quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock worth $77,000 after purchasing an additional 556 shares during the last quarter. Inspire Investing LLC boosted its holdings in Sabra Healthcare REIT by 2.3% in the fourth quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock valued at $469,000 after purchasing an additional 565 shares in the last quarter. Finally, Natixis Advisors LLC boosted its holdings in Sabra Healthcare REIT by 2.2% in the third quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock valued at $516,000 after purchasing an additional 598 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Barclays began coverage on shares of Sabra Healthcare REIT in a research report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 price target for the company. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Truist Financial raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price objective for the company in a research note on Wednesday, July 8th. Finally, Wells Fargo & Company raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Five investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.45.

Sabra Healthcare REIT Stock Up 0.7%

Shares of NASDAQ:SBRA opened at $19.76 on Tuesday. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm has a market cap of $4.98 billion, a price-to-earnings ratio of 31.37, a PEG ratio of 1.46 and a beta of 0.65. The stock’s 50-day moving average price is $19.65 and its two-hundred day moving average price is $19.72. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period last year, the company earned $0.37 earnings per share. The company’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.1%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.